As of September 30, 2026, Astera Labs, Inc. carries a market capitalization of 54.35B, placing it among publicly traded companies globally. Its enterprise value stands at 53.13B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 54.35B |
| Enterprise Value | 53.13B |
Astera Labs, Inc.'s next confirmed earnings release is scheduled for February 16, 2027.
| Earnings Date | 2/16/2027 |
As of September 30, 2026, Astera Labs, Inc. has 174.75M shares outstanding.
| Shares Outstanding | 174.75M |
As of September 30, 2026, Astera Labs, Inc. trades at a trailing price-to-earnings ratio of 131.18. The price-to-sales ratio is 38.89, and the price-to-book ratio stands at 30.81.
| PE Ratio | 131.18 |
| PS Ratio | 38.89 |
| PB Ratio | 30.81 |
| P/TBV Ratio | 32.29 |
| P/FCF Ratio | 186.57 |
| P/OCF Ratio | 138.56 |
As of September 30, 2026, Astera Labs, Inc. trades at an EV/EBITDA multiple of 145.94 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 38.70 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 151.65 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 53.13B versus a market cap of 54.35B, with the gap driven by net debt and cash on the balance sheet.
| EV / Sales | 38.70 |
| EV / EBITDA | 145.94 |
| EV / EBIT | 151.65 |
As of September 30, 2026, Astera Labs, Inc. maintains a current ratio of 8.03, meaning it holds 8.0x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 8.03 |
| Quick Ratio | 7.04 |
Over the twelve months ended September 30, 2026, Astera Labs, Inc. posted a return on equity (ROE) of 28.21, showing how much profit the company earns on every dollar of shareholder capital. Return on assets (ROA) stands at 24.93, measuring how efficiently the asset base is converted into earnings. The company generates approximately 1.82M in revenue per employee across its workforce of 756.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 3.22 indicates how many times Astera Labs, Inc. sells and replaces its inventory over a year, a key working capital efficiency ratio.
| Return on Equity (ROE) | 28.21 |
| Return on Assets (ROA) | 24.93 |
| Revenue Per Employee | 1.82M |
| Employee Count | 756.00 |
| Inventory Turnover | 3.22 |
Over the twelve months ended September 30, 2026, Astera Labs, Inc. recorded an income tax benefit of -12.48M rather than an expense, typically from losses, carryforwards, or the release of a tax provision. Taxes are levied on pretax income of 394.55M, leaving 407.03M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.
| Income Tax | -12.48M |
As of the close on November 17, 2026, Astera Labs, Inc.'s stock has gained approximately 48.81% over the past 52 weeks. The 50-day moving average sits at 258.45, while the 200-day moving average is 228.34.
| 52-Week Price Change | 48.81% |
| 50-Day Moving Average | 258.45 |
| 200-Day Moving Average | 228.34 |
Over the twelve months ended September 30, 2026, Astera Labs, Inc. generated 1.37B in revenue and converted that into 407.03M in net income, yielding earnings per share of 2.23. EBITDA reached 364.06M, while operating income came in at 350.36M.
| Revenue | 1.37B |
| Gross Profit | 1.01B |
| Operating Income | 350.36M |
| Pretax Income | 394.55M |
| Net Income | 407.03M |
| EBITDA | 364.06M |
| EBIT | 350.36M |
| Earnings Per Share (EPS) | 2.23 |
These figures are as of September 30, 2026. Total book value stands at 1.76B, with working capital of 1.51B providing operational flexibility.
| Cash & Cash Equivalents | 1.22B |
| Net Debt | -184.75M |
| Equity (Book Value) | 1.76B |
| Book Value Per Share | 10.10 |
| Working Capital | 1.51B |
Astera Labs, Inc. produced 385.34M in operating cash flow over the twelve months ended September 30, 2026. After subtracting -81.22M in capital expenditures, free cash flow totaled 304.12M - equivalent to 1.77 per share.
| Operating Cash Flow | 385.34M |
| Capital Expenditures | -81.22M |
| Free Cash Flow | 304.12M |
| FCF Per Share | 1.77 |
Over the twelve months ended September 30, 2026, Astera Labs, Inc. posted a gross margin of 73.89, reflecting its pricing power and cost economics. The operating margin of 25.52 and net profit margin of 29.64 provide insight into operational efficiency.
| Gross Margin | 73.89 |
| Operating Margin | 25.52 |
| Pretax Margin | 28.73 |
| Profit Margin | 29.64 |
| EBITDA Margin | 26.51 |
These figures cover the twelve months ended September 30, 2026. Free cash flow yield stands at 0.54, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield is negative at -0.02, meaning Astera Labs, Inc. raised more capital through share issuance and new debt than it returned via dividends and buybacks.
| Shareholder Yield | -0.02 |
| FCF Yield | 0.54 |
As of September 30, 2026, Astera Labs, Inc. has an Altman Z-Score of 125.34, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 125.34 |